Home » Stocks » FGEN » Statistics

FibroGen, Inc. (FGEN)

Stock Price: $18.57 USD -0.24 (-1.28%)
Updated Apr 9, 2021 4:00 PM EDT - Market closed
After-hours: $18.68 +0.11 (0.59%) Apr 9, 7:56 PM

Total Valuation

FibroGen has a market cap or net worth of $1.72 billion. The enterprise value is $1.07 billion.

Market Cap 1.72B
Enterprise Value 1.07B

Important Dates

The next estimated earnings date is May 6, 2021, which is a Thursday.

Estimated Earnings Date May 6, 2021
Ex-Dividend Date n/a

Share Statistics

FibroGen has 89.85 million shares outstanding. The number of shares has increased by 3.72% in one year.

Shares Outstanding 89.85M
Share Change (YoY) +3.72%
Share Change (QoQ) -0.78%
Owned by Insiders (%) 8.03%
Owned by Institutions (%) 79.97%
Float 84.97M

Valuation Ratios

PE Ratio n/a
Forward PE 61.35
PS Ratio 9.77
PB Ratio 4.08
P/FCF Ratio 22.19
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 6.09
EV / EBIT n/a
EV / FCF 13.83

Financial Position

The company has a current ratio of 4.63, with a Debt / Equity ratio of 0.09.

Current Ratio 4.63
Quick Ratio 4.46
Debt / Equity 0.09
Debt / EBITDA -0.23
Debt / FCF 0.49

Financial Efficiency

Return on Equity (ROE) -38.76%
Return on Assets (ROA) -14.24%
Return on Capital (ROIC) -59.40%
Revenue Per Employee $294,356
Profits Per Employee -$316,012
Employee Count 599
Asset Turnover n/a
Inventory Turnover 0.76


In the past 12 months, FibroGen has paid $360,000 in income taxes. This is 0.20% of the company's revenue.

Income Tax 360,000
Effective Tax Rate -0.19%
Taxes as % of Revenue 0.20%

Stock Price Statistics

The stock price has decreased by -49.00% in the last 52 weeks. The beta is 1.19, so FibroGen's price volatility has been higher than the market average.

Beta (1Y) 1.19
52-Week Price Change -49.00%
50-Day Moving Average 35.53
200-Day Moving Average 41.66
Average Volume (30 Days) 2,412,614

Short Selling Information

The latest short interest is 8.51 million, so 9.47% of the outstanding shares have been sold short.

Short Interest 8.51M
Short % of Shares Out 9.47%
Short Ratio (days to cover) 6.18

Income Statement

In the last 12 months, FibroGen had revenue of $176.32 million and -$189.29 million in losses. Earnings per share was -$2.11.

Revenue 176.32M
Gross Profit 167.45M
Operating Income -191.88M
Pretax Income -188.93M
Net Income -189.29M
EBITDA -164.48M
EBIT -186.53M
Earnings Per Share (EPS) -$2.11
Full Income Statement

Balance Sheet

The company has $686.54 million in cash and $37.72 million in debt, giving a net cash position of $648.82 million or $7.22 per share.

Cash & Cash Equivalents 686.54M
Total Debt 37.72M
Net Cash 648.82M
Net Cash Per Share $7.22
Book Value 422.18M
Book Value Per Share 4.70
Working Capital 591.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $81.60 million and capital expenditures -$3.99 million, giving a free cash flow of $77.61 million.

Operating Cash Flow 81.60M
Capital Expenditures -3.99M
Free Cash Flow 77.61M
FCF Per Share $0.86
Cash Flow Statement


Gross margin is 94.97%, with operating and profit margins of -108.83% and -107.36%.

Gross Margin 94.97%
Operating Margin -108.83%
Pretax Margin -107.15%
Profit Margin -107.36%
EBITDA Margin -93.29%
EBIT Margin -105.79%
FCF Margin 44.02%

Dividends & Yields

FibroGen does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -10.99%
FCF Yield 4.51%
Dividend Growth (YoY) n/a
Payout Ratio n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a